ThermoDox heat-activated liposome: Phase II started

Celsion began a double-blind, sham-controlled, North American Phase II trial to compare 50 mg/m 2 IV ThermoDox plus radiofrequency ablation (RFA) vs. RFA alone in 88 patients with colorectal cancer me...